Spirotryprostatin B

From Wikipedia, the free encyclopedia

Spirotryprostatin B
Properties
Molecular formula	C21H21N3O3
Molar mass	363.41 g/mol
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references

Spirotryprostatin B is an indolic alkaloid found in the Aspergillus fumigatus fungus. Spirotryprostatin B and several other indolic alkaloids (including Spirotryprostatin A, as well as other tryprostatins and cyclotryprostatins) have been found to have anti-mitotic properties, and as such they have become of great interest as anti-cancer drugs^[1]. Because of this, the total syntheses of these compounds is a major pursuit of organic chemists, and a number of different syntheses have been published in the chemical literature.

The first total synthesis was accomplished in 2000 by the Danishefsky group at Columbia University^[2], with a number of other syntheses following shortly thereafter by Williams^[3], Ganesan^[4], Fuji^[5], Carreira^[6], Horne^[7], Overman^[8], and most recently Trost^[9].

From a synthetic point of view, the most challenging structural features of the molecule are the C3 spirocyclic ring juncture and the adjacent prenyl-substituted carbon. Approaches toward preparing the skeleton of spirotryprostatin B have varied considerably.

Danishefsky spirotryprostatin B synthesis

In the Danishefsky synthesis, an amine derived from tryptophan was condensed with an aldehyde, triggering a Mannich-type reaction wherein the pendant oxindole acted as a nucleophile toward the intermediate iminium species.

Williams spirotryprostatin B synthesis

The synthesis by the Williams group utilized a 3-component coupling reaction. A secondary amine was combined with an aldehyde to form an intermediate azomethine ylide, which underwent a 1,3-dipolar cycloaddition with an unsaturated oxindole also present in the reaction mixture.

Ganesan spirotryprostatin B synthesis

Ganesan made use of a biomimetic strategy in his synthesis of spirotryprostatin B. An indole was treated with N-bromosuccinimide to trigger an oxidative rearrangement, forming the quaternary stereocenter in a diastereoselective manner.

Fuji spirotryprostatin B synthesis

In the synthesis developed by the Fuji group, the stereochemistry at the spirocyclic carbon was established by a nitroolefination reaction. An oxindole with pendant prenyl group was reacted with a nitroolefin bearing a chiral leaving group.

Carreira spirotryprostatin B synthesis

The Carreira group made use of a magnesium iodide promoted annulation reaction in their approach toward spirotryprostatin B. An oxindole bearing a cyclopropane was reacted with an imine in the presence of the magnesium iodide, triggering the ring-expansion reaction.

Horne spirotryprostatin B synthesis

Horne's synthesis of spirotryprostatin B also made use of a Mannich-type process, wherein a chloro-indole served as the pro-nucleophile. The cyclization was triggered by treating the pendant imine with the acyl chloride derived from proline. The resulting iminium species was attacked by the chloro-indole, forming the spirocyclic bond.

Overman spirotryprostatin B synthesis

The Overman group utilized a Heck reaction to prepare the molecule. An iodo-aniline with a tethered alkene was subjected to palladium catalysis. The intermediate palladium-allyl species was intercepted by the pendant amide nitrogen to generate the prenyl stereocenter in the same reaction.

Trost spirotryprostatin B synthesis

In the synthesis developed by the Trost group, the stereochemistry at the spirocyclic ring juncture is established by a decarboxylation-prenylation sequence, reminiscent of the Carroll reaction. Here, a prenyl ester serves as both the nucleophile and electrophile precursor. Upon treatment with a chiral palladium catalyst the prenyl group ionizes and decarboxylates. The resulting ion pair subsequently recombines to generate the prenylated product. Notably, double bond migration occurs and the prenyl group is attacked at the oxindole carbon.

[edit] References

1. ^ Cui, CB et al (1996). "Spirotryprostatin B, a novel mammalian cell cycle inhibitor produced by Aspergillus fumigatus". J. Antibiot. 49: 832–835. PMID 8823522. 
2. ^ Nussbaum, FN; Danishefsky, SJ (2000). "A Rapid Total Synthesis of Spirotryprostatin B: Proof of Its Relative and Absolute Stereochemistry". Angew. Chem. Int. Ed. 39 (12): 2175–2178. doi:10.1002/1521-3773(20000616)39:12<2175::AID-ANIE2175>3.0.CO;2-J. 
3. ^ Sebahar, PR; Williams, RM (2000). "The Asymmetric Total Synthesis of (+)- and (-)-Spirotryprostatin B". J. Am. Chem. Soc. 122 (23): 5666–5667. doi:10.1021/ja001133n. 
4. ^ Wang, H; Ganesan, A (2000). "A Biomimetic Total Synthesis of (-)-Spirotryprostatin B and Related Studies". J. Org. Chem. 65 (15): 4685–4693. doi:10.1021/jo000306o. 
5. ^ Bagul, TD et al (2002). "Total Synthesis of Spirotryprostatin B via Asymmetric Nitroolefination". Org. Lett. 4 (2): 249–251. doi:10.1021/ol016999s. 
6. ^ Meyers, C; Carreira, EM (2003). "Total Synthesis of (-)-Spirotryprostatin B". Angew. Chem. Int. Ed. 42 (6): 694–696. doi:10.1002/anie.200390192. 
7. ^ Miyake, FY et al (2004). "Preparation and Synthetic Applications of 2-Halotryptophan Methyl Esters: Synthesis of Spirotryprostatin B". Angew. Chem. Int. Ed. 43 (40): 5357–5360. doi:10.1002/anie.200460419. 
8. ^ Overman, LE; Rosen, MD (2000). "Total Synthesis of (-)-Spirotryprostatin B and Three Stereoisomers". Angew. Chem. Int. Ed. 39 (24): 4596–4599. doi:10.1002/1521-3773(20001215)39:24<4596::AID-ANIE4596>3.0.CO;2-F. 
9. ^ Trost, BM; Stiles, DT (2007). "Total Synthesis of Spirotryprostatin B via Diastereoselective Prenylation". Org. Lett. 9 (15): 2763–2766. doi:10.1021/ol070971k.